Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Working Capital Changes (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Other Working Capital Changes for 8 consecutive years, with $16.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 62.98% year-over-year to $16.1 million, compared with a TTM value of -$5.0 million through Dec 2025, down 37.28%, and an annual FY2025 reading of -$5.0 million, down 37.28% over the prior year.
  • Other Working Capital Changes was $16.1 million for Q4 2025 at Arcturus Therapeutics Holdings, up from -$19.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $43.4 million in Q4 2024 and bottomed at -$35.1 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is $1.3 million, with a median of -$1.1 million recorded in 2021.
  • The sharpest move saw Other Working Capital Changes plummeted 2678.52% in 2022, then soared 805.53% in 2023.
  • Year by year, Other Working Capital Changes stood at -$2.7 million in 2021, then soared by 163.95% to $1.7 million in 2022, then crashed by 2135.05% to -$35.1 million in 2023, then skyrocketed by 223.58% to $43.4 million in 2024, then crashed by 62.98% to $16.1 million in 2025.
  • Business Quant data shows Other Working Capital Changes for ARCT at $16.1 million in Q4 2025, -$19.0 million in Q3 2025, and -$862000.0 in Q2 2025.